Wound Care - Americas

Americas

Highlights

Revenue in the Wound Care market amounts to US$1.29bn in 2024. The market is expected to grow annually by 0.33% (CAGR 2024-2029).
In global comparison, most revenue is generated United States (US$1bn in 2024).
In relation to total population figures, per person revenues of US$1.27 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureMethodology

The Wound Care market in Americas is experiencing significant growth due to several factors. Customer preferences for advanced wound care products, increasing prevalence of chronic wounds, and rising geriatric population are driving the growth of the market.

Additionally, local special circumstances and underlying macroeconomic factors are also contributing to the development of the market. Customer preferences in the Americas are shifting towards advanced wound care products. Patients are increasingly demanding products that offer faster healing, reduced pain, and improved overall wound care experience.

This has led to a rise in the adoption of advanced wound dressings, negative pressure wound therapy, and bioactive wound care products. Manufacturers are focusing on developing innovative products that cater to these preferences, further driving the growth of the market. The prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is increasing in the Americas.

This can be attributed to factors such as sedentary lifestyle, aging population, and the high prevalence of diabetes. Chronic wounds require specialized wound care products and treatments for proper healing. As the number of patients with chronic wounds continues to rise, the demand for wound care products is also increasing, thereby fueling the market growth.

The Americas has a significant geriatric population, which is more prone to developing chronic wounds due to age-related factors such as reduced skin elasticity and slower healing process. The aging population is expected to further increase in the coming years, creating a larger customer base for wound care products. This demographic trend is driving the growth of the market as manufacturers focus on developing products that meet the unique needs of the elderly population.

Local special circumstances in the Americas also contribute to the development of the Wound Care market. The region has a well-established healthcare infrastructure, which enables easy access to wound care products and treatments. Additionally, the presence of key market players and research institutions in the region fosters innovation and drives market growth.

Moreover, the Americas has a high healthcare expenditure, which allows for greater investment in wound care products and technologies. Underlying macroeconomic factors such as economic growth, healthcare spending, and government initiatives also play a role in the development of the Wound Care market in the Americas. As the economy grows, individuals have more disposable income to spend on healthcare, including wound care products.

Moreover, government initiatives aimed at improving healthcare infrastructure and increasing awareness about wound care contribute to market growth. In conclusion, the Wound Care market in the Americas is experiencing significant growth due to customer preferences for advanced wound care products, increasing prevalence of chronic wounds, and the rising geriatric population. Local special circumstances such as a well-established healthcare infrastructure and presence of key market players also contribute to the market development.

Underlying macroeconomic factors such as economic growth and government initiatives further drive the growth of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.